Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smita Raghava

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Biochemistry|May 9, 2013
SV40 late protein VP4 forms toroidal pores to disrupt membranes for viral releaseSmita Raghava, Kristina M Giorda, Fabian B Romano, et al.
Plos Pathogens|July 9, 2011
The SV40 late protein VP4 is a viroporin that forms pores to disrupt membranes for viral releaseSmita Raghava, Kristina M Giorda, Fabian B Romano, et al.
Biotechnology and Bioengineering|November 8, 2024
Implementation of Innovative Process Analytical Technologies to Characterize Critical Quality Attributes of Co-Formulated Monoclonal Antibody ProductsApurva Godbole, Lyufei Chen, Jay Desai, et al.
Molecular Pharmaceutics|October 23, 2023
Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation AssayNoemi P Meza, Colin A Hardy, Kylie H Morin, et al.
Protein Science : a Publication of the Protein Society|September 11, 2008
Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodiesSmita Raghava, Bipasha Barua, Pradeep K Singh, et al.
Mabs|December 14, 2018
Structure, heterogeneity and developability assessment of therapeutic antibodiesYingda Xu, Dongdong Wang, Bruce Mason, et al.
Mabs|April 7, 2020
Predicting Antibody Developability Profiles Through Early Stage Discovery ScreeningMarc Bailly, Carl Mieczkowski, Veronica Juan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Biochemistry|May 9, 2013
SV40 late protein VP4 forms toroidal pores to disrupt membranes for viral releaseSmita Raghava, Kristina M Giorda, Fabian B Romano, et al.
Plos Pathogens|July 9, 2011
The SV40 late protein VP4 is a viroporin that forms pores to disrupt membranes for viral releaseSmita Raghava, Kristina M Giorda, Fabian B Romano, et al.
Biotechnology and Bioengineering|November 8, 2024
Implementation of Innovative Process Analytical Technologies to Characterize Critical Quality Attributes of Co-Formulated Monoclonal Antibody ProductsApurva Godbole, Lyufei Chen, Jay Desai, et al.
Molecular Pharmaceutics|October 23, 2023
Predicting Colloidal Stability of High-Concentration Monoclonal Antibody Formulations in Common Pharmaceutical Buffers Using Improved Polyethylene Glycol Induced Protein Precipitation AssayNoemi P Meza, Colin A Hardy, Kylie H Morin, et al.
Protein Science : a Publication of the Protein Society|September 11, 2008
Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodiesSmita Raghava, Bipasha Barua, Pradeep K Singh, et al.
Mabs|December 14, 2018
Structure, heterogeneity and developability assessment of therapeutic antibodiesYingda Xu, Dongdong Wang, Bruce Mason, et al.
Mabs|April 7, 2020
Predicting Antibody Developability Profiles Through Early Stage Discovery ScreeningMarc Bailly, Carl Mieczkowski, Veronica Juan, et al.
Pageof 2